Lansoprazole Capsule, Delayed Release
Product Images NDC 50090-6154

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 50090-6154). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1.jpg (Figure 1)

This is a chart that shows the mean severity of day heartburn by study day for evaluable patients. The severity is rated from 3 for severe to 0 for none. The chart compares the results for a placebo group, a group taking Lansoprazole 15 mg daily, and a group taking Lansoprazole 30 mg daily. The data is presented for study days 18, 20, and 25.*

FDA Label Image

Figure-2.jpg (Figure 2)

This is a chart that shows the mean severity of night heartburn by study day for evaluable patients. The severity level ranges from 0 (none) to 3 (severe), and it compares the results of a placebo group to two different doses of lansoprazole (15mg and 30mg). The chart is shown over a period of 18 days from the start of treatment.*

FDA Label Image

Formula-structure.jpg (Image 01)

FDA Label Image

Label Image (Lbl500906154)

This appears to be a description of a medication product labeled as "Rlsoprazole Delayed-Release" with a strength of "30 MG" and comes in a pack containing "30 capsules". The product should be stored at a temperature between "68-77 degrees" Fahrenheit. However, the first text "mC_sonn" and "Prndu:i e 00" are not clear, hence the complete description cannot be provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.